Europska Unija - hrvatski - EMA (European Medicines Agency)

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - cjepiva - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. korištenje ovog cjepiva mora se provoditi u skladu sa službenim preporukama.

Europska Unija - hrvatski - EMA (European Medicines Agency)

roche registration gmbh - pirfenidone - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - imunosupresivi - esbriet is indicated in adults for the treatment of idiopathic pulmonary fibrosis.

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

heaton k.s., na pankraci 332/14, prag,Češka - bendamustinum - prašak za koncentrat za otopinu za infuziju - 2,5 mg/ml - urbroj: jedna bočica sadrži 25 mg bendamustinklorida; jedna bočica sadrži 100 mg bendamustinklorida; nakon rekonstitucije 1 ml koncentrata sadrži 2,5 mg bendamustinklorida

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

fresenius kabi d.o.o., radnička cesta 37a, zagreb, hrvatska - bendamustinklorid - prašak za koncentrat za otopinu za infuziju - 2,5 mg/ml - urbroj: jedna bočica sadrži 25 mg bendamustinklorida; jedna bočica sadrži 100 mg bendamustinklorida; nakon rekonstitucije 1 ml koncentrata sadrži 2,5 mg bendamustinklorida

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

sandoz d.o.o., maksimirska 120, zagreb, hrvatska - acetilcistein - granule za oralnu otopinu - 200 mg - urbroj: jedna vrećica (5 g granula) sadrži 200 mg acetilcisteina

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

sandoz d.o.o., maksimirska 120, zagreb, hrvatska - acetilcistein - oralni prašak u vrećici - 600 mg - urbroj: svaka vrećica sadrži 600 mg acetilcisteina

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

sandoz d.o.o., maksimirska 120, zagreb, hrvatska - acetilcistein - granule za oralnu otopinu - 100 mg - urbroj: jedna vrećica (5 g granula) sadrži 100 mg acetilcisteina

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

sandoz d.o.o., maksimirska 120, zagreb - acetilcistein - oralna otopina - 20 mg/ml - urbroj: 1 ml oralne otopine sadrži 20 mg acetilcisteina

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

teva b.v., swensweg 5, haarlem, nizozemska - bendamustinklorid - prašak za koncentrat za otopinu za infuziju - 2,5 mg/ml - urbroj: 1 ml koncentrata sadrži 2,5 mg bendamustinklorid nakon rekonstitucije jedna bočica od 26 ml sadrži 25 mg bendamustinklorida jedna bočica od 60 ml sadrži 100 mg bendamustinklorida

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

sandoz d.o.o., maksimirska 120, zagreb, hrvatska - acetilcistein - šumeća tableta - 600 mg - urbroj: jedna šumeća tableta sadrži 600 mg acetilcisteina